Pharmaceutical Compliance

Colgate stands behind each of its quality products and is careful to comply with the high standards set forth in each state. View your state's compliance reports from the column to the left.

Beginning July 1, 2009, Massachusetts state law requires manufacturers to give any Massachusetts-licensed prescriber (e.g. dentists, nurse practitioners, and other Massachusetts-licensed health care practitioners with prescribing authority) the opportunity to restrict the use of their prescriber data before such information is (i) used by manufacturers for marketing purposes or (ii) provided to sales representatives. If you no longer wish to receive marketing materials from Colgate Oral Pharmaceuticals or prefer not to be contacted by one of our Oral Care Consultants, please select one of the choices below and complete the requested information so that we are able to remove your contact information from our system.

Colgate Oral Pharmaceuticals (“COP”) declares that, to the best of its knowledge, and based on a good faith understanding of the statutory requirements of California Health and Safety Code sections 119400 and 119402, COP has adopted a Comprehensive Compliance and Ethics Program (“CCEP”) applicable to COP’s operations and dealings with California dental health professionals. COP has tailored its CCEP to meet the specific nature and needs of the Company, and regularly assesses the effectiveness of its CCEP to enable it to implement necessary adjustments or refinements. As of the date of this declaration, COP believes it is in compliance with its CCEP and with California Health & Safety Code section 119400 and 119402 in all material respects, and is not aware of any violations that have not been addressed or with respect to which corrective action has not been taken. COP has made this declaration in good faith in the absence of clarifying regulations or guidance from the State of California.

The U.S. Department of Health and Human Services, Office of the Inspector General has recognized in its Compliance Program Guidance for Pharmaceutical Manufacturers that the implementation of an effective compliance program may not entirely eliminate improper conduct from the operations of a pharmaceutical manufacturer.

By making this declaration, COP is not asserting that in all circumstances it can prevent individual employees from conduct that deviates from its policies. COP expects employees to comply with its CCEP and has made a good faith effort to enforce its CCEP, prevent violations, and address any inappropriate conduct that may occur. Copies of this declaration and the CCEP may be obtained by calling 1-800-778-6080 if located in the U.S. Outside the U.S. please call collect 212-310-2330.

November 1, 2010

Read the full California compliance and ethics plan